Evidence mapPaperPMID 40229443Full record

ArticleScientific reports2025

Mipep deficiency in adipocytes impairs mitochondrial protein maturation and leads to systemic inflammation and metabolic dysfunctions.

Yuka Nozaki, Masaki Kobayashi, Tomoyoshi Fukuoh, Mamiko Ishimatsu, Takumi Narita, Kanari Taki, Yuto Hirao, Shota Ayabe, Miku Yokoyama, Yuina Otani and 10 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Yuka Nozaki *Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.ORCID http://orcid.org/0009-0002-4656-3274
Masaki Kobayashi *Laboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.ORCID https://orcid.org/0000-0002-0985-0322
Tomoyoshi FukuohLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.ORCID http://orcid.org/0009-0009-6524-523X
Mamiko IshimatsuLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.ORCID http://orcid.org/0009-0003-9761-7364
Takumi NaritaLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.ORCID http://orcid.org/0000-0002-8939-4346
Kanari TakiLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
Yuto HiraoLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
Shota AyabeLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
Miku YokoyamaLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.
Yuina OtaniLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.ORCID http://orcid.org/0009-0003-1805-7187
Yuhei MizunoeLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan.ORCID http://orcid.org/0000-0001-6716-1544
Mami MatsumotoSection of Electron Microscopy, Supportive Center for Brain Research, National Institute for Physiological Sciences, Okazaki, Japan.ORCID http://orcid.org/0000-0003-1406-5916
Nobuhiko OhnoDepartment of Anatomy, Division of Histology and Cell Biology, School of Medicine, Jichi Medical University, Shimotsuke, Japan.ORCID http://orcid.org/0000-0002-6536-2753
Tomonori KaifuDivision of Immunology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.ORCID http://orcid.org/0000-0002-2614-1472
Shogo OkazakiResearch Institute for Biomedical Sciences (RIBS), Tokyo University of Science, Noda, Japan.ORCID http://orcid.org/0009-0008-2243-5140
Ryo GoitsukaResearch Institute for Biomedical Sciences (RIBS), Tokyo University of Science, Noda, Japan.ORCID http://orcid.org/0000-0002-1137-9760
Yoshimi NakagawaDivision of Complex Biosystem Research, Department of Research and Development, Institute of Natural Medicine, University of Toyama, Toyama, Japan.ORCID http://orcid.org/0000-0001-8710-5232
Hitoshi ShimanoDepartment of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.ORCID http://orcid.org/0000-0002-5562-5572
Yoichiro IwakuraResearch Institute for Biomedical Sciences (RIBS), Tokyo University of Science, Noda, Japan.ORCID http://orcid.org/0000-0002-9934-5775
Yoshikazu HigamiLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan. higami@rs.tus.ac.jp.ORCID http://orcid.org/0000-0003-1381-0777

Funding

Japan Society for the Promotion of Science 17H02179Japan Society for the Promotion of Science 17K13231Japan Society for the Promotion of Science 22K17814Uehara Memorial Foundation K19-170
6 · The paper itself

Abstract

Most mitochondrial proteins encoded in the nuclear genome are synthesized in the cytoplasm. These proteins subsequently undergo maturation through the cleavage of a signal sequence at the N-terminus by one or two mitochondrial signal peptidases, which is essential for their function within mitochondria. The present study demonstrates that adipocyte-specific knockout of one mitochondrial signal peptidase, mitochondrial intermediate peptidase (MIPEP), resulted in disordered mitochondrial proteostasis of MIPEP substrate proteins and their defective maturation. MIPEP deficiency in white and brown adipocytes suppressed the expression of adipocyte differentiation, lipid metabolism, and mitochondrial biogenesis genes. These alterations led to lipoatrophy in white adipose tissue and the whitening of brown adipose tissue. Additionally, it induced an atypical mitochondrial unfolded protein response and local inflammation in white and brown adipose tissue. Furthermore, it induced fatty liver and splenomegaly and caused systemic impairments in glucose metabolism and inflammation. These findings indicate that maturation defects of certain mitochondrial proteins and subsequent proteostasis disorders in white and brown adipocytes cause chronic and systemic inflammatory and metabolic dysfunctions.

Indexed as

AdipocytesInflammationMetabolic DiseasesMitochondrial ProteinsAdipocytes, BrownAdipose Tissue, BrownAdipose Tissue, WhiteAnimalsLipid MetabolismMaleMiceMice, KnockoutMitochondriaUnfolded Protein ResponseMitochondrial Proteins

Identifiers

PMID40229443
PMCPMC11997187

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.